Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression

References

• Peters T, Ausmeier K, Rüther U. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mammal Genome. 1999;10(10):983–986. doi:10.1007/s003359901144
   PubMed Web of Science ®Google Scholar
• Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724–726. doi:10.1038/ng2048
   PubMed Web of Science ®Google Scholar
• Yang J, Loos RJ, Powell JE, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature. 2012;490(7419):267–272. doi:10.1038/nature11401
   PubMed Web of Science ®Google Scholar
• Anselme I, Laclef C, Lanaud M, Rüther U, Schneider-Maunoury S. Defects in brain patterning and head morphogenesis in the mouse mutant Fused toes. Dev Biol. 2007;304(1):208–220. doi:10.1016/j.ydbio.2006.12.025
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (New York, NY). 2007;316(5826):889–894. doi:10.1126/science.1141634
   Google Scholar
• Robbens S, Rouzé P, Cock JM, Spring J, Worden AZ, Van de Peer Y. The FTO gene, implicated in human obesity, is found only in vertebrates and marine algae. J Mol Evol. 2008;66(1):80–84. doi:10.1007/s00239-007-9059-z
   PubMed Web of Science ®Google Scholar
• Gulati P, Avezov E, Ma M, et al. Fat mass and obesity-related (FTO) shuttles between the nucleus and cytoplasm. Biosci Rep. 2014;34(5):e00144. doi:10.1042/bsr20140111
   PubMed Web of Science ®Google Scholar
• Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science (New York, NY). 2007;318(5855):1469–1472. doi:10.1126/science.1151710
   Google Scholar
• Jia G, Yang CG, Yang S, et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 2008;582(23–24):3313–3319. doi:10.1016/j.febslet.2008.08.019
   PubMed Web of Science ®Google Scholar
• Han Z, Niu T, Chang J, et al. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature. 2010;464(7292):1205–1209. doi:10.1038/nature08921
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–120. doi:10.1038/nature12730
   PubMed Web of Science ®Google Scholar
• Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518(7540):560–564. doi:10.1038/nature14234
   PubMed Web of Science ®Google Scholar
• Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626–641. doi:10.1038/cr.2017.31
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–887. doi:10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42. doi:10.1038/nrm.2016.132
   PubMed Web of Science ®Google Scholar
• Ping X-L, Sun B-F, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177–189. doi:10.1038/cr.2014.3
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93–95. doi:10.1038/nchembio.1432
   PubMed Web of Science ®Google Scholar
• Yang G, Sun Z, Zhang N. Reshaping the role of m6A modification in cancer transcriptome: a review. Cancer Cell Int. 2020;20:353. doi:10.1186/s12935-020-01445-y
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao BS, Roundtree IA, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6):1388–1399. doi:10.1016/j.cell.2015.05.014
   PubMed Web of Science ®Google Scholar
• Mauer J, Luo X, Blanjoie A, et al. Reversible methylation of m(6)A(m) in the 5ʹ cap controls mRNA stability. Nature. 2017;541(7637):371–375. doi:10.1038/nature21022
   PubMed Web of Science ®Google Scholar
• Wei J, Liu F, Lu Z, et al. Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(6):973–985.e975. doi:10.1016/j.molcel.2018.08.011
   PubMed Web of Science ®Google Scholar
• Zhang X, Wei LH, Wang Y, et al. Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates. Proc Natl Acad Sci USA. 2019;116(8):2919–2924. doi:10.1073/pnas.1820574116
   PubMed Web of Science ®Google Scholar
• Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3(7):e115. doi:10.1371/journal.pgen.0030115
   PubMed Web of Science ®Google Scholar
• Karra E, O’Daly OG, Choudhury AI, et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013;123(8):3539–3551. doi:10.1172/jci44403
   PubMed Web of Science ®Google Scholar
• Berulava T, Horsthemke B. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. EJHG. 2010;18(9):1054–1056. doi:10.1038/ejhg.2010.71
   PubMed Web of Science ®Google Scholar
• Hernández-Caballero ME, Sierra-Ramírez JA. Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview. Mol Biol Rep. 2015;42(3):699–704. doi:10.1007/s11033-014-3817-y
   PubMed Web of Science ®Google Scholar
• Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52. doi:10.1186/1471-2350-12-52
   PubMed Web of Science ®Google Scholar
• Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013;45(4):428–432, 432e421. doi:10.1038/ng.2571
   PubMed Web of Science ®Google Scholar
• Huang X, Zhao J, Yang M, Li M, Zheng J. Association between FTO gene polymorphism (rs9939609 T/A) and cancer risk: a meta-analysis. Eur J Cancer Care (Engl). 2017;26(5):e12464. doi:10.1111/ecc.12464
   Web of Science ®Google Scholar
• Tung YCL, Yeo GSH, O’Rahilly S, Coll AP. Obesity and FTO: changing focus at a complex locus. Cell Metab. 2014;20(5):710–718. doi:10.1016/j.cmet.2014.09.010
   PubMed Web of Science ®Google Scholar
• Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31(1):127–141. doi:10.1016/j.ccell.2016.11.017
   PubMed Web of Science ®Google Scholar
• Guibal FC, Moog-Lutz C, Smolewski P, et al. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J Biol Chem. 2002;277(1):218–224. doi:10.1074/jbc.M108476200
   PubMed Web of Science ®Google Scholar
• Glasow A, Prodromou N, Xu K, von Lindern M, Zelent A. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood. 2005;105(1):341–349. doi:10.1182/blood-2004-03-1074
   PubMed Web of Science ®Google Scholar
• Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18(1):46. doi:10.1186/s12943-019-1004-4
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang R, Zhang L, Li J, Lou K, Shi B. The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K/AKT signaling pathway. Oncol Lett. 2017;13(6):4685–4690. doi:10.3892/ol.2017.6038
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhou D, Lai Y, et al. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Lett. 2012;319(1):89–97. doi:10.1016/j.canlet.2011.12.033
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128. doi:10.1016/j.gene.2019.02.076
   PubMed Web of Science ®Google Scholar
• Cui Q, Shi H, Ye P, et al. mA RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 2017;18(11):2622–2634. doi:10.1016/j.celrep.2017.02.059
   PubMed Web of Science ®Google Scholar
• Wu R, Li A, Sun B, et al. A novel mA reader Prrc2a controls oligodendroglial specification and myelination. Cell Res. 2019;29(1):23–41. doi:10.1038/s41422-018-0113-8
   PubMed Web of Science ®Google Scholar
• Ding Y, Qi N, Wang K, et al. FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA demethylation. Onco Targets Ther. 2020;13:1461–1470. doi:10.2147/ott.S231914
   PubMed Web of Science ®Google Scholar
• Liu J, Ren D, Du Z, Wang H, Zhang H, Jin Y. m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochem Biophys Res Commun. 2018;502(4):456–464. doi:10.1016/j.bbrc.2018.05.175
   PubMed Web of Science ®Google Scholar
• Li J, Han Y, Zhang H, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 2019;512(3):479–485. doi:10.1016/j.bbrc.2019.03.093
   PubMed Web of Science ®Google Scholar
• Bojagora A, Saridakis V. USP7 manipulation by viral proteins. Virus Res. 2020;286:198076. doi:10.1016/j.virusres.2020.198076
   PubMed Web of Science ®Google Scholar
• Su Y, Huang J, Hu J. mA RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gastric cancer. Front Oncol. 2019;9:1038. doi:10.3389/fonc.2019.01038
   PubMed Web of Science ®Google Scholar
• Xu D, Shao W, Jiang Y, Wang X, Liu Y, Liu X. FTO expression is associated with the occurrence of gastric cancer and prognosis. Oncol Rep. 2017;38(4):2285–2292. doi:10.3892/or.2017.5904
   PubMed Web of Science ®Google Scholar
• Tang X, Liu S, Chen D, Zhao Z, Zhou J. The role of the fat mass and obesity-associated protein in the proliferation of pancreatic cancer cells. Oncol Lett. 2019;17(2):2473–2478. doi:10.3892/ol.2018.9873
   PubMed Web of Science ®Google Scholar
• Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang CV. MYC and metabolism on the path to cancer. Semin Cell Dev Biol. 2015;43:11–21. doi:10.1016/j.semcdb.2015.08.003
   PubMed Web of Science ®Google Scholar
• Yue C, Chen J, Li Z, Li L, Chen J, Guo Y. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. J Exp Clin Cancer Res. 2020;39(1):240. doi:10.1186/s13046-020-01731-7
   PubMed Web of Science ®Google Scholar
• Zou D, Dong L, Li C, Yin Z, Rao S, Zhou Q. The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int. 2019;19:321. doi:10.1186/s12935-019-1045-1
   PubMed Web of Science ®Google Scholar
• Yang Z, Jiang X, Zhang Z, et al. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Cancer Gene Ther. 2021;28(1–2):141–155. doi:10.1038/s41417-020-0193-8
   PubMed Web of Science ®Google Scholar
• Xu Y, Ye S, Zhang N, et al. The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun. 2020;40(10):484–500. doi:10.1002/cac2.12075
   PubMed Web of Science ®Google Scholar
• Garg S, Sharma M, Ung C, et al. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity. 2011;35(2):182–193. doi:10.1016/j.immuni.2011.06.009
   PubMed Web of Science ®Google Scholar
• Dykes SS, Gray AL, Coleman DT, et al. The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo. Oncotarget. 2016;7(21):31037–31052. doi:10.18632/oncotarget.8832
   PubMedGoogle Scholar
• Shi H, Zhao J, Han L, et al. Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO. Aging. 2020;12(17):17022–17037. doi:10.18632/aging.103622
   PubMedGoogle Scholar
• Li Y, Zheng D, Wang F, Xu Y, Yu H, Zhang H. Expression of demethylase genes, FTO and ALKBH1, is associated with prognosis of gastric cancer. Dig Dis Sci. 2019;64(6):1503–1513. doi:10.1007/s10620-018-5452-2
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shen J, Gao L, Feng Y. Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway. Oncol Rep. 2016;35(4):2391–2397. doi:10.3892/or.2016.4613
   PubMed Web of Science ®Google Scholar
• Li J, Zhu L, Shi Y, Liu J, Lin L, Chen X. m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation. Am J Transl Res. 2019;11(9):6084–6092.
   PubMed Web of Science ®Google Scholar
• Formica V, Doldo E, Antonetti FR, et al. Biological and predictive role of ERCC1 polymorphisms in cancer. Crit Rev Oncol Hematol. 2017;111:133–143. doi:10.1016/j.critrevonc.2017.01.016
   PubMed Web of Science ®Google Scholar
• Zhou S, Bai ZL, Xia D, et al. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Mol Carcinog. 2018;57(5):590–597. doi:10.1002/mc.22782
   PubMed Web of Science ®Google Scholar
• Mittenbühler MJ, Saedler K, Nolte H, et al. Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo. Mol Metabol. 2020;42:101085. doi:10.1016/j.molmet.2020.101085
   PubMed Web of Science ®Google Scholar
• Zhao Y, You S, Yu YQ, et al. Decreased nuclear expression of FTO in human primary hepatocellular carcinoma is associated with poor prognosis. Int J Clin Exp Pathol. 2019;12(9):3376–3383.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zhuang C, Luo X, et al. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis. J Cell Mol Med. 2019;23(3):2163–2173. doi:10.1111/jcmm.14128
   PubMed Web of Science ®Google Scholar
• Huang H, Wang Y, Kandpal M, et al. FTO-dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling. Cancer Res. 2020;80(16):3200–3214. doi:10.1158/0008-5472.Can-19-4044
   PubMed Web of Science ®Google Scholar
• Chen B, Ye F, Yu L, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134(43):17963–17971. doi:10.1021/ja3064149
   PubMed Web of Science ®Google Scholar
• Yan F, Al-Kali A, Zhang Z, et al. A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors. Cell Res. 2018;28(11):1062–1076. doi:10.1038/s41422-018-0097-4
   PubMed Web of Science ®Google Scholar
• Huang Y, Su R, Sheng Y, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35(4):677–691.e610. doi:10.1016/j.ccell.2019.03.006
   PubMed Web of Science ®Google Scholar
• Su R, Dong L, Li C, et al. R-2HG exhibits anti-tumor activity by targeting FTO/m(6)A/MYC/CEBPA signaling. Cell. 2018;172(1–2):90–105.e123. doi:10.1016/j.cell.2017.11.031
   PubMed Web of Science ®Google Scholar
• Zheng G, Cox T, Tribbey L, et al. Synthesis of a FTO inhibitor with anticonvulsant activity. ACS Chem Neurosci. 2014;5(8):658–665. doi:10.1021/cn500042t
   PubMed Web of Science ®Google Scholar
• Singh B, Kinne HE, Milligan RD, Washburn LJ, Olsen M, Lucci A. Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge. PLoS One. 2016;11(7):e0159072. doi:10.1371/journal.pone.0159072
   PubMed Web of Science ®Google Scholar
• Huang Y, Yan J, Li Q, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015;43(1):373–384. doi:10.1093/nar/gku1276
   PubMed Web of Science ®Google Scholar